Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Dishman Carbogen Amcis Ltd

NSE: DCAL · BSE: 540701 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹168.19
Market cap: ₹2,637 Cr
Revenue (annual): ₹2,932 Cr
Net profit (annual): ₹97.45 Cr
P/E (TTM): 163.2×Sector 50.4×
Promoter holding: 59.32%+0.00% QoQ
FII holding: 6.86%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Debt & Borrowing 4 Earnings Call 3 Financial Results 2 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 Aug 2026 19:54 IST BSE

Financial Results

Dishman Carbogen Amcis Q1 FY27 Results: Net Loss of ₹57.9 Cr

Dishman Carbogen Amcis Ltd reported revenue from operations of ₹677.6 Cr (-4.3% YoY) and a net loss of ₹57.9 Cr for Q1 FY27.

Key figure: Net loss ₹57.9 Cr

Open full results → Read the filing ↗

19 May 2026 23:30 IST NSE

Financial Results

Dishman Carbogen Amcis Q4 FY26 Results: Net Profit ₹21.7 Cr, Down 49.7% YoY

Dishman Carbogen Amcis Ltd reported revenue from operations of ₹851.4 Cr (+18.9% YoY) and net profit of ₹21.7 Cr (-49.7% YoY) for Q4 FY26.

Key figure: Net profit ₹21.7 Cr · -49.7% YoY

Open full results → Read the filing ↗